chronic plaque psoriasis

Arcutis Biotherapeutics Files for $100 Million IPO
CP Wire
Mon, 01/6/20 - 02:28 pm
Arcutis Biotherpeutics
IPOs
ARQ-151
chronic plaque psoriasis
Arcutis Biotherapeutics Files for $100 Million IPO
Mon, 01/6/20 - 02:25 pm
Arcutis Biotherpeutics
IPOs
ARQ-151
chronic plaque psoriasis
Tremfya Demonstrates Superiority Over Cosentyx in Ph III Data in Moderate to Severe Plaque Psoriasis
CP Wire
Wed, 12/12/18 - 10:50 am
Tremfya
Cosentyx
Jannsen
chronic plaque psoriasis
Tremfya Demonstrates Superiority Over Cosentyx in Ph III Data in Moderate to Severe Plaque Psoriasis
Wed, 12/12/18 - 10:46 am
Tremfya
Cosentyx
Jannsen
chronic plaque psoriasis
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
CP Wire
Wed, 09/12/18 - 11:08 am
Janssen Pharmaceuticals
JNJ
chronic plaque psoriasis
Tremfya
Humira
AbbVie
clinical trials
Ph III Trial Shows Improved Outcomes with Tremfya after Failure With Humira
Wed, 09/12/18 - 09:16 am
Janssen Pharmaceuticals
JNJ
chronic plaque psoriasis
Tremfya
Humira
Why This FDA Approval for Valeant Is Not as Good as First Thought
Yahoo/24-7 Wall St
Thu, 02/16/17 - 03:24 pm
Valeant Pharmaceuticals
FDA
Siliq
chronic plaque psoriasis
With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?
Fierce Pharma
Thu, 02/16/17 - 10:11 am
Siliq
Amgen
AstraZeneca
Valeant Pharmaceuticals
chronic plaque psoriasis
FDA declines to expand approval of Pfizer arthritis drug
Yahoo/Reuters
Thu, 10/15/15 - 08:45 am
FDA
Pfizer
Xeljanz
chronic plaque psoriasis
Eli Lilly Uncovers Positive Data from Ixekizumab Studies
Yahoo/Zacks
Sat, 08/23/14 - 09:41 am
Eli Lilly
ixekizumab
chronic plaque psoriasis
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Yahoo
Tue, 04/22/14 - 09:25 am
Pfizer
chronic plaque psoriasis
tofacitinib
Pfizer announces top-line results of two Phase 3 trials of Tofacitinib
Yahoo/Fly on the Wall
Wed, 10/9/13 - 08:47 am
Pfizer
tofacitinib
chronic plaque psoriasis
Janus kinase inhibitor
Novartis tests copy of Amgen's Enbrel in late-stage trial
Reuters
Mon, 06/24/13 - 10:44 am
Amgen
Enbrel
generics
Sandoz
Novartis
chronic plaque psoriasis
Actelion's psoriasis drug meets main goal in trial
Reuters
Tue, 12/18/12 - 12:51 pm
Actelion
ponesimod
chronic plaque psoriasis